slides · global inventory
Callout
Component collection for the active corpus filters, with each row opening the slide detail view.
Matching slides 96,741
Current window 85,681-85,710
Pages 3,225
Rows per page 30
Component
85,681-85,710 of 96,741
12
The slide highlights the first-in-class potential of the CAB-ROR2-ADC therapy.BioAtla | Investor Conference Presentation Deck | 15 slides · BioAtla
Conference presentation Investor relations 1 hit
06
The slide combines a bar chart for revenue projections and a segmented pie/fan chart for patient population sizing.Bionomics | Investor Presentation Deck | 16 slides · Bionomics
Pitch deck Investor relations Beat · Agitate (Make it worse)Loop · Cost Of Inaction1 hit
09
Includes a list of key metrics and a bottom banner highlighting broader societal impact.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Problem StatementLoop · Logic Chain1 hit
22
The slide highlights step 2 (Mapping of mutations) and provides a visual representation of DNA sequencing comparing normal and cancer cells.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
26
The chart uses a broken y-axis to show high-frequency outliers alongside the long tail of low-frequency targets.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Loop · Golden Circle1 hit
31
The slide uses a combination of microscopy images and a line chart to demonstrate efficacy.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
35
Includes chemical structure of PSAR-LNP components and a line chart comparing in vivo expression profiles.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
38
The slide uses a 5-step process diagram to illustrate the workflow, with a specific focus on step 3 (Neoantigen prediction) being powered by AI/ML.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
42
The ROC curve shows the new model (blue) consistently outperforming the baseline NetMHCpan 4.1 EL (orange).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
43
The slide illustrates a multi-stage computational pipeline (Structural modeling -> EWS score -> ML modeling) and compares detection timing against WHO designations.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
49
The slide uses a map-based visualization to communicate operational scale and geographic reach.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
63
FIH stands for first-in-human.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
64
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
67
The table highlights that all tested Omicron-modified vaccines met the superiority criterion (lower bound of 95% CI for GMR > 1.0).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
68
The table highlights that all tested Omicron-modified vaccines met the super superiority criterion (GMR lower bound > 1.5).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Market Opportunity1 hit
77
Data shows neutralization titers for OMI and Bivalent vaccines against BA.1 and BA.4/5 variants.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
80
BioNTech | Investor Day Presentation Deck | 156 slidesBioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
85
Includes citations at the bottom.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
86
The slide uses a structural biology diagram to explain the modularity of endolysins.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
87
Shows log-scale reduction in CFU/ml for pathogens vs no significant impact on beneficial bacteria.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations 1 hit
106
Kaplan-Meier plot showing significant difference in RFS between responders and non-responders.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
108
The slide uses a combination of metrics and a callout box to frame the clinical problem.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
109
Includes a citation to a Nature article and specific trial results (Lipo-MERIT).BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
113
The slide uses a process flow diagram to illustrate the trial design.BioNTech | Investor Day Presentation Deck | 156 slides · BioNTech
Conference presentation Investor relations Beat · Product Pipeline1 hit
21
The slide includes a detailed footnote defining organic vs inorganic growth strategies.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
26
Internal company illustrative estimates based on historical results.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
30
Cano Health | Investor Day Presentation Deck | 105 slidesCano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
43
Uses a before-after framing to demonstrate clinical efficacy compared to industry benchmarks.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
69
The slide uses a laurel wreath icon to emphasize the NPS score.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit
72
The slide uses a problem-solution structure, highlighting specific demographic disparities and ranking data.Cano Health | Investor Day Presentation Deck | 105 slides · Cano Health
Conference presentation Investor relations 1 hit